Position in INCY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$71,189
+$12,082 QoQ
Shares Held
628
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#690
of 854 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avanza Fonder AB holds $21,519,303 across 6 Biotechnology names. INCY ranks #5 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
28,198 | $14,006,791 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,517 | $7,181,310 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
399 | $120,110 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,649 | $92,458 | |
| 5 | INCY |
Incyte Corp
This page
|
628 | $71,189 | |
| 6 | INSM |
INSMED Inc
|
445 | $47,445 |
All Filings in INCY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,189 | 628 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $59,107 | 628 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $289,889 | 2,935 | Shares | Sole | 2026-01-12 | |
| No filing history on record for this holder in this stock. | ||||||